Aptuit, Inc. has completed the acquisition of Evotec‘s Chemical and Pharmaceutical Development (CPD) business. The move allows Aptuit to integrate an API facility in Oxford, England and a recently expanded parenteral fill/finish facility in Glasgow, Scotland into its global network. According to an Aptuit statement, “The integration of these development and small-scale manufacturing facilities in Europe completes a unique global API supply chain where small scale development takes...